Cited by 1,733Renin-Angiotensin System StudiesEicosanoids and Hypertension PharmacologyCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Crackower, Michael A., Sarao, Renu, Oudit, Gavin Y., Yagil, Chana, Kozieradzki, Ivona, Scanga, Sam E., Oliveira-dos-Santos, Antonio J., da Costa, Joan, Zhang, Liyong, Pei, York, Scholey, James, Ferrario, Carlos M., Manoukian, Armen S., Chappell, Mark C., Backx, Peter H., Yagil, Yoram, Penninger, Josef M.·2002·Nature

DOI 10.1038/nature00786

Open this paper in CoChat — free account

Abstract

Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.

Integrity signals

Registry

Crossref · 10.1038/nature00786

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citation
Global Burden of Cardiovascular Diseases
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 3,014
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Essential Hypertension
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
The Berkeley Drosophila Genome Project Gene Disruption Project: Single P-Element Insertions Mutating 25% of Vital Drosophila Genes
Spradling, A. C., Stern, D., Beaton, A., Rehm, E. J., Laverty, T., Mozden, N., Misra, S., & Rubin, G. M. (1999) · Genetics · doi:10.1093/genetics/153.1.135 · Cited by 786

Show all 44 references

Sorted by citations

Items 301–400 of 999

Defective intestinal amino acid absorption in Ace2 null mice
Singer, D., Camargo, S. M. R., Ramadan, T., Schäfer, M., Mariotta, L., Herzog, B., Huggel, K., Wolfer, D. P., Werner, S., Penninger, J. M., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00140.2012 · Cited by 115
Self-citation
Synergistic Expression of Angiotensin-Converting Enzyme (ACE) and ACE2 in Human Renal Tissue and Confounding Effects of Hypertension on the ACE to ACE2 Ratio
Wakahara, S., Konoshita, T., Mizuno, S., Motomura, M., Aoyama, C., Makino, Y., Kato, N., Koni, I., & Miyamori, I. (2007) · Endocrinology · doi:10.1210/en.2006-1287 · Cited by 114
Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular Treatments
Trask, A. J., & Ferrario, C. M. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00012.x · Cited by 114
Self-citation
Role of angiotensin‐converting enzyme 2 and angiotensin(1–7) in 17β‐oestradiol regulation of renal pathology in renal wrap hypertension in rats
Ji, H., Menini, S., Zheng, W., Pesce, C. M., Wu, X., & Sandberg, K. L. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041392 · Cited by 114
Hypothesis
Yagil, Y., & Yagil, C. (2003) · Hypertension · doi:10.1161/01.hyp.0000063886.71596.c8 · Cited by 114
Self-citation
Angiotensin-Converting Enzymes Play a Dominant Role in Fertility
Pan, P., Zhan, Q., Fang, L., Zheng, Y., & Jin, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141021071 · Cited by 113
Enzyme Inhibitors and Activators
Şentürk, M. (2017) · InTech eBooks · doi:10.5772/63325 · Cited by 113
Smoking and COVID-19: What we know so far
Shastri, M. D., Shukla, S. D., Chong, W. C., Rajendra, K. C., Dua, K., Patel, R. P., Peterson, G. M., & O’Toole, R. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106237 · Cited by 110
Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy
Dong, B., Yu, Q. T., Dai, H. Y., Gao, Y., Zhou, Z. L., Zhang, L., Jiang, H., Gao, F., Li, S. Y., Zhang, Y. H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.071 · Cited by 112
Self-citation
Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
Zhong, J., Ye, J.-Y., Jin, H., Yu, X., Yu, H., Zhu, D., Gao, P., Huang, D., Shuster, M., Loibner, H., et al. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.09.005 · Cited by 113
Self-citation
Cancer and COVID-19: Unmasking their ties
Addeo, A., & Friedlaender, A. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102041 · Cited by 118
Perinatally administered losartan augments renal ACE 2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
Klimas, J., Olvedy, M., Ochodnicka‐Mackovicova, K., Kružliak, P., Čačányiová, S., Kristek, F., Křenek, P., & Ochodnický, P. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12573 · Cited by 111
Angiotensin-Converting Enzyme 2 (ACE2) and ACE Activities Display Tissue-Specific Sensitivity to Undernutrition-Programmed Hypertension in the Adult Rat
Rivière, G., Michaud, A., Breton, C., Camp, G. V., Laborie, C., Enache, M., Lésage, J., DELOOF, S., Corvol, P. L., & Vieau, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000185148.27901.fe · Cited by 114
Shorter telomere lengths in patients with severe COVID-19 disease
Sánchez-Vazquez, R., Guío-Carrión, A., Zapatero, A., Martínez, P., & Blasco, M. A. (2021) · Aging · doi:10.18632/aging.202463 · Cited by 110
Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy-0
Schindler, C., Bramlage, P., Kirch, W., & Ferrario, C. M. (2011) · PubMed Central · doi:10.6084/m9.figshare.62679 · Cited by 111
Self-citation
Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men
Lieb, W., Graf, J., Götz, A., König, I. R., Mayer, B., Fischer, M., Stritzke, J., Hengstenberg, C., Holmer, S. R., Döring, A., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0718-5 · Cited by 111
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Garreta, E., Prado, P., Stanifer, M. L., Monteil, V., Marco, A., Ullate‐Agote, A., Moya‐Rull, D., Vilas‐Zornoza, A., Tarantino, C., Romero, J. P., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.009 · Cited by 112
Self-citation
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation
Neves, L. A. A., Stovall, K., Joyner, J., Valdés, G., Gallagher, P. E., Ferrario, C. M., Merrill, D., & Brosnihan, K. B. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00514.2007 · Cited by 109
Self-citation
Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice
Niu, M.-J., Yang, J., Lin, S., Ji, X., & Guo, L. (2008) · Endocrine · doi:10.1007/s12020-008-9110-x · Cited by 108
Murine Recombinant Angiotensin-Converting Enzyme 2
Ye, M., Wysocki, J. A., González‐Pacheco, F. R., Salem, M., Evora, K., Garcia-Halpin, L., Poglitsch, M., Schuster, M., & BATLLE, D. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.198622 · Cited by 108
Pathological Role of Angiotensin II in Severe COVID-19
Miesbach, W. (2020) · TH Open · doi:10.1055/s-0040-1713678 · Cited by 110
Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes
Guo, H., Hu, B., Yang, X., Zeng, L., Li, B., Ouyang, S., & Shi, Z. (2020) · Journal of Virology · doi:10.1128/jvi.00902-20 · Cited by 109
The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
Chow, R. D.-W., Majety, M., & Chen, S. (2021) · Nature Communications · doi:10.1038/s41467-020-20323-9 · Cited by 106
Polymorphisms of ACE2 Gene are Associated With Essential Hypertension and Antihypertensive Effects of Captopril in Women
Fan, X., Wang, Y., Sun, K., Zhang, W., Yang, X., Wang, S., Zhen, Y., Wang, J., Li, W., Han, Y., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100214 · Cited by 107
Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?
Yan, T., Xiao, R., & Lin, G. (2020) · The FASEB Journal · doi:10.1096/fj.202000782 · Cited by 106
New Physiological Concepts of the Renin-Angiotensin System From the Investigation of Precursors and Products of Angiotensin I Metabolism
Ferrario, C. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.145839 · Cited by 106
Self-citation
Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis
Ramchand, J., Patel, S. K., Kearney, L. G., Matalanis, G. S., Farouque, O., Srivastava, P., & Burrell, L. M. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.09.005 · Cited by 105
Novel Aspects of the Renal Renin-Angiotensin System: Angiotensin-(1-7),ACE2 and Blood Pressure Regulation
Chappell, M. C., Modrall, J. G., Diz, D. I., & Ferrario, C. M. (2004) · KARGER eBooks · doi:10.1159/000078713 · Cited by 105
Self-citation
Angiotensin II Type 1 Receptor–Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice
Xia, H., Feng, Y., Obr, T. D., Hickman, P. J., & Lazartigues, E. D. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123844 · Cited by 105
Angiotensin-(1-9) Attenuates Cardiac Fibrosis in the Stroke-Prone Spontaneously Hypertensive Rat via the Angiotensin Type 2 Receptor
Flores‐Muñoz, M., Work, L. M., Douglas, K. B., Denby, L., Dominiczak, A. F., Graham, D., & Nicklin, S. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.177485 · Cited by 107
Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1-7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2–Null Mice
Patel, V. B., Bodiga, S., Dong, F., Das, S. K., Wang, Z., Wang, W., Basu, R., Zhong, J., Kassiri, Z., & Oudit, G. Y. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.191650 · Cited by 105
Self-citation
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
Dariya, B., & Nagaraju, G. P. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.001 · Cited by 105
ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
Singh, H., Choudhari, R. H., Nema, V., & Khan, A. A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104621 · Cited by 106
Comparative Proteomics Profiling of a Phospholamban Mutant Mouse Model of Dilated Cardiomyopathy Reveals Progressive Intracellular Stress Responses
Gramolini, A. O., Kislinger, T., Alikhani‐Koupaei, R., Fong, V., Thompson, N. J., Isserlin, R., Sharma, P., Oudit, G. Y., Trivieri, M. G., Fagan, A., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700245-mcp200 · Cited by 104
Self-citation
ACE2 and Microbiota
Cole‐Jeffrey, C. T., Liu, M., Katovich, M. J., Raizada, M. K., & Shenoy, V. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000307 · Cited by 101
The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease
Chen, L., & Hao, G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa093 · Cited by 104
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Martínez-Salazar, B., Holwerda, M., Stüdle, C., Piragyte, I., Mercader, N., Engelhardt, B., Rieben, R., & Döring, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824851 · Cited by 106
Mechanisms of Disease: local renin–angiotensin–aldosterone systems and the pathogenesis and treatment of cardiovascular disease
Ré, R. N. (2004) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0012 · Cited by 103
MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides
Gallagher, P. E., Ferrario, C. M., & Tallant, E. A. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00145.2008 · Cited by 100
Self-citation
Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
Verma, A., Xu, K., Du, T., Zhu, P., Liang, Z., Liao, S., Zhang, J., Raizada, M. K., Grant, M. B., & Li, Q. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.06.007 · Cited by 102
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Saponaro, F., Rutigliano, G., Sestito, S., Bandini, L., Storti, B., Bizzarri, R., & Zucchi, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.588618 · Cited by 106
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli
Singh, R., Singh, A. K., & Leehey, D. J. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00159.2003 · Cited by 98
Eccentric and concentric cardiac hypertrophy induced by exercise training: microRNAs and molecular determinants
Fernandes, T. M., Soci, Ú. P. R., & de Oliveira, E. M. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500112 · Cited by 105
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Wicik, Z., Eyileten, C., Jakubik, D., Simões, S. N., Martins, D., Pavão, R., Siller-Matula, J. M., & Postula, M. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113743 · Cited by 100
COVID‐19 and ischemic stroke
Sagris, D., Papanikolaou, A., Kvernland, A., Korompoki, E., Frontera, J. A., Troxel, A. B., Gavriatopoulou, M., Milionis, H. J., Lip, G. Y. H., Michel, P., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15008 · Cited by 106
Angiotensin1‐9 antagonises pro‐hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor
Flores‐Muñoz, M., Smith, N. J., Haggerty, C., Milligan, G., & Nicklin, S. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.203075 · Cited by 101
Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options
Grace, J., Herath, C. B., Mak, K. Y., Burrell, L. M., & Angus, P. (2012) · Clinical Science · doi:10.1042/cs20120030 · Cited by 104
Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China
Zhou, Y., He, Y., Yang, H., He, Y., Wang, T., Zhu, C., Yao, R., & Liang, Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233328 · Cited by 98
Sex‐related differences in COVID‐19 lethality
Penna, C. R. R., Mercurio, V., Tocchetti, C. G., & Pagliaro, P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15207 · Cited by 109
Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation
Lin, C., & Pan, C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7408-8 · Cited by 100
Is nicotine exposure linked to cardiopulmonary vulnerability to COVID‐19 in the general population?
Olds, J. L., & Kabbani, N. (2020) · FEBS Journal · doi:10.1111/febs.15303 · Cited by 104
Variants in ACE2; potential influences on virus infection and COVID-19 severity
Bakhshandeh, B., Sorboni, S. G., Javanmard, A., Mottaghi, S. S., Mehrabi, M., Sorouri, F., Abbasi, A., & Jahanafrooz, Z. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104773 · Cited by 101
Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
Law, J. P., Pickup, L. C., Pavlović, D., Townend, J., & Ferro, C. J. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00751-4 · Cited by 111
Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
Patel, V. B., Parajuli, N., & Oudit, G. Y. (2013) · Clinical Science · doi:10.1042/cs20130344 · Cited by 98
Self-citation
Angiotensin-Converting Enzyme 2 Is a Critical Determinant of Angiotensin II–Induced Loss of Vascular Smooth Muscle Cells and Adverse Vascular Remodeling
Patel, V. B., Zhong, J., Dong, F., Basu, R., Morton, J. S., Parajuli, N., McMurtry, M. S., Davidge, S. T., Kassiri, Z., & Oudit, G. Y. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03388 · Cited by 98
Self-citation
COVID-19 and RAS: Unravelling an Unclear Relationship
D’Ardes, D., Boccatonda, A., Rossi, I., Guagnano, M. T., Santilli, F., Cipollone, F., & Bucci, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083003 · Cited by 99
Angiotensin II Blockade and Renal Protection
Kobori, H., Mori, H., Masaki, T., & Nishiyama, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319170009 · Cited by 100
Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421
Lambert, D., Lambert, L. A., Clarke, N. E., Hooper, N. M., Porter, K. E., & Turner, A. J. (2014) · Clinical Science · doi:10.1042/cs20130420 · Cited by 96
FGF23 and Phosphate–Cardiovascular Toxins in CKD
Vogt, I., Haffner, D., & Leifheit‐Nestler, M. (2019) · Toxins · doi:10.3390/toxins11110647 · Cited by 100
Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
Bautista-Vargas, M. A., Bonilla‐Abadía, F., & Cañas, C. A. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02172-x · Cited by 97
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
Monteil, V., Dyczynski, M., Lauschke, V. M., Kwon, H., Wirnsberger, G., Youhanna, S. C., Zhang, H., Slutsky, A. S., del Pozo, C. H., Horn, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013426 · Cited by 97
Self-citation
Retinoic Acid and the Heart
Pan, J., & Baker, K. M. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75010-5 · Cited by 96
Type 1 angiotensin receptor pharmacology: Signaling beyond G proteins
Oro, C., Qian, H., & Thomas, W. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.10.001 · Cited by 98
Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender
Zhang, Q., Cong, M., Wang, N., Li, X., Zhang, H., Zhang, K., Jin, M., Wu, N., Qiu, C., & Li, J. (2018) · Medicine · doi:10.1097/md.0000000000012917 · Cited by 96
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
Baig, M. S., Alagumuthu, M., Rajpoot, S., & Saqib, U. (2020) · Drugs in R&D · doi:10.1007/s40268-020-00312-5 · Cited by 96
Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
Lubel, J. S., Herath, C. B., Tchongue, J., Grace, J., Jia, Z., Spencer, K., CASLEY, D. J., Crowley, P. F., Sievert, W., Burrell, L. M., et al. (2009) · Clinical Science · doi:10.1042/cs20080647 · Cited by 95
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease
Bernardi, S., Michelli, A., Zuolo, G., Candido, R., & Fabris, B. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8917578 · Cited by 93
Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
Peron, J. P. S., & Nakaya, H. I. (2020) · Clinics · doi:10.6061/clinics/2020/e1912 · Cited by 93
ACE2: A novel therapeutic target for cardiovascular diseases
Sarkissian, S. D., Huentelman, M. J., Stewart, J. M., Katovich, M. J., & Raizada, M. K. (2005) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2005.05.011 · Cited by 94
The Uterine Placental Bed Renin-Angiotensin System in Normal and Preeclamptic Pregnancy
Anton, L., Merrill, D., Neves, L. A. A., Diz, D. I., Corthorn, J. L., Valdés, G., Stovall, K., Gallagher, P. E., Moorefield, C., Gruver, C., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0076 · Cited by 94
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
Katalin, Ú., Fagyas, M., Siket, I. M., Kertész, A., Csanádi, Z., Sándorfi, G., Clemens, M., Fedor, R., Papp, Z., Edes, I. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087845 · Cited by 92
Angiotensin II regulation of angiotensin‐converting enzymes in spontaneously hypertensive rat primary astrocyte cultures
Gowrisankar, Y. V., & Clark, M. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13641 · Cited by 92
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Lee, C.-H., & Choi, W. J. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01301-7 · Cited by 93
BNip3 and signal-specific programmed death in the heart
Webster, K. A., Graham, R. M., & Bishopric, N. H. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.007 · Cited by 92
Membrane-associated zinc peptidase families: comparing ACE and ACE2
Guy, J. L., Lambert, D., Warner, F. J., Hooper, N. M., & Turner, A. J. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.010 · Cited by 91
Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies
Ghatage, T., Goyal, S., Dhar, A., & Bhat, A. (2021) · Hypertension Research · doi:10.1038/s41440-021-00643-z · Cited by 93
Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis
Qin, R., He, L., Yang, Z., Jia, N., Chen, R., Xie, J., Fu, W., Chen, H., Lin, X., Huang, R., et al. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08908-8 · Cited by 97
The ACE2 gene: its potential as a functional candidate for cardiovascular disease
Burrell, L. M., Harrap, S. B., Velkoska, E., & Patel, S. K. (2012) · Clinical Science · doi:10.1042/cs20120269 · Cited by 90
Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
Shim, K. Y., Eom, Y. W., Kim, M. Y., Kang, S. H., & Baik, S. K. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.317 · Cited by 94
Fiend and friend in the renin angiotensin system: An insight on acute kidney injury
Sharma, N., Anders, H., & Gaikwad, A. B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.018 · Cited by 89
Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes
Patel, S. K., Wai, B., Ord, M., MacIsaac, R. J., Grant, S., Velkoska, E., Panagiotopoulos, S., Jerums, G., Srivastava, P., & Burrell, L. M. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.188 · Cited by 89
Pharmacologic modulation of ACE2 expression
Soler, M. J., Barrios, C., Oliva, R., & BATLLE, D. C. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0076-0 · Cited by 88
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
Labò, N., Ohnuki, H., & Tosato, G. (2020) · Cells · doi:10.3390/cells9071583 · Cited by 92
Hypertension, a Moving Target in COVID-19
Savoia, C., Volpe, M., & Kreutz, R. H. (2021) · Circulation Research · doi:10.1161/circresaha.121.318054 · Cited by 100
Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation
Gramolini, A. O., Trivieri, M. G., Oudit, G. Y., Kislinger, T., Li, W., Patel, M. M., Emili, A., Kranias, E. G., Backx, P. H., & MacLennan, D. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510883103 · Cited by 89
Self-citation
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation
Campbell, D. J., Zeitz, C. J., Esler, M., & Horowitz, J. D. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00020 · Cited by 88
Angiotensin-Converting Enzyme 2 Deficiency Is Associated With Impaired Gestational Weight Gain and Fetal Growth Restriction
Bharadwaj, M. S., Strawn, W. B., Groban, L., Yamaleyeva, L. M., Chappell, M. C., Horta, C., Atkins, K., Firmes, L. B., Gurley, S. B., & Brosnihan, K. B. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179358 · Cited by 88
Self-citation
Identification of angiotensin converting enzyme 2 in the rodent retina
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Thomas, M. C., Lew, R. A., Yarski, M. A., Smith, A. I., & Cooper, M. E. (2004) · Current Eye Research · doi:10.1080/02713680490517944 · Cited by 88
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
Hum, C., Loiselle, J., Ahmed, N., Shaw, T. A., Toudic, C., & Pezacki, J. P. (2021) · Drugs · doi:10.1007/s40265-021-01474-5 · Cited by 87
Edema formation in congestive heart failure and the underlying mechanisms
Abassi, Z. A., Khoury, E. E., Karram, T., & Aronson, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.933215 · Cited by 122
ACE2 Overexpression Ameliorates Left Ventricular Remodeling and Dysfunction in a Rat Model of Myocardial Infarction
Zhao, Y. X., Yin, H. Q., Yu, Q. T., Qiao, Y., Dai, H. Y., Zhang, M. X., Zhang, L., Liu, Y., Wang, L. C., Liu, D. S., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.160 · Cited by 87
Self-citation
No association of Angiotensin-Converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension*1
Benjafield, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.022 · Cited by 87
Working outside the system: an update on the unconventional behavior of the renin–angiotensin system components
Kurdi, M., Mello, W. C. D., & Booz, G. W. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.01.012 · Cited by 87
Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung
Wiener, R. S., Cao, Y., Hinds, A., Ramirez, M. I., & Williams, M. C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21248 · Cited by 86
Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats
Santos, S. H. S., Giani, J. F., Burghi, V., Miquet, J. G., Qadri, F., Braga, J. F., Todiraş, M., Kotnik, K., Alenina, N. V., Dominici, F. P., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1087-0 · Cited by 86
Lifetime Overproduction of Circulating Angiotensin-(1-7) Attenuates Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Dysfunction and Remodeling
Santiago, N. M., Guimarães, P. S., Sirvente, R. A., Oliveira, L. A. M., Irigoyen, M. C., Santos, R. A. S., & Campagnole‐Santos, M. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.149815 · Cited by 86
Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade
Igase, M., Kohara, K., Nagai, T., Miki, T., & Ferrario, C. M. (2008) · Hypertension Research · doi:10.1291/hypres.31.553 · Cited by 85
Self-citation
A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome
Khiali, S., Khani, E., & Entezari‐Maleki, T. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1693 · Cited by 87
Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin‐converting enzyme 2 expression
Burchill, L. J., Velkoska, E., Dean, R. G., Lew, R. A., Smith, A. I., Levidiotis, V., & Burrell, L. M. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040386 · Cited by 85
Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
Lambert, D., Hooper, N. M., & Turner, A. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.012 · Cited by 86

Authors: Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C. M., Manoukian, A. S., Chappell, M. C., Backx, P. H., Yagil, Y., & Penninger, J. M.
Affiliations: University of Toronto (CA)
Institute of Molecular Biotechnology (AT)
University Health Network (CA)
Barzilai Medical Center (IL)
Atrium Health Wake Forest Baptist (US)
Corresponding author: Penninger, Josef M.
ORCID: Crackower, Michael A.
Oudit, Gavin Y.
Kozieradzki, Ivona
Zhang, Liyong
Pei, York
Scholey, James
Ferrario, Carlos M.
Chappell, Mark C.
Backx, Peter H.
Yagil, Yoram
Penninger, Josef M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2002-06
Volume: 417
Issue: 6891
Pages: 822-828
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature00786
OpenAlex: W2025672718
Cited by: 1,733
References: 44
Citations by year: 2026: 12 · 2025: 25 · 2024: 38 · 2023: 88 · 2022: 117 · 2021: 215 · 2020: 311 · 2019: 38 · 2018: 22 · 2017: 33 · 2016: 42 · 2015: 38 · 2014: 53 · 2013: 54 · 2012: 60
FWCI: 38.64
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amgen
German-Israeli Foundation for Scientific Research and Development
Canada Research Chairs
Israel Science Foundation
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: angiotensin-converting enzyme 2, ACE2, cardiac function, hypertension, quantitative trait loci, X chromosome, cardiac contractility, angiotensin II, hypoxia, Acer, cardiac morphogenesis, rat model, mouse knockout
MeSH terms: Angiotensin II, Animals, Hypoxia, Blood Pressure, Cloning, Molecular, Drosophila melanogaster, Female, Heart, Hypertension, Peptidyl-Dipeptidase A, Male, Metalloendopeptidases, Myocardial Contraction, Myocardium, X Chromosome, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Quantitative Trait, Heritable, Radiation Hybrid Mapping, Drosophila Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks